Stocks News

LAST PRICE
59.2200
TODAY'S CHANGE (%)
Trending Down-0.0500 (-0.0844%)

Bid / Lots
59.0100/ 1
Ask / Lots
59.3400/ 3
Open / Previous Close
59.3300 / 59.2700
Day Range
Low 58.9550
High 59.5350
52 Week Range
Low 39.3500
High 61.0800
Volume
4,581,577
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 29, 2024
- Astrazeneca's Enhertu, Orpathys Among 91 Drugs Added to China's National Reimbursement Drug List, from 8:09AM ET on Friday Nov 29, 2024 by MT Newswires
  8:09AM ET on Friday Nov 29, 2024 by MT Newswires
  Companies Mentioned: JNJ, MRK, SNY, ZLAB, AZN, BMY, BGNE
  08:09 AM EST, 11/29/2024 (MT Newswires) -- Astrazeneca (AZN) confirmed Friday in an emailed statement to MT Newswires that its breast cancer treatment Enhertu and cancer treatment Orpathys have been added to China's National Reimbursement Drug List ...
Nov 26, 2024
- Bristol Myers Squibb to Participate in Citi's 2024 Global Healthcare Conference, from 6:59AM ET on Tuesday Nov 26, 2024 by Dow Jones
  6:59AM ET on Tuesday Nov 26, 2024 by Dow Jones
  Companies Mentioned: BMY
  
  Bristol Myers Squibb to Participate in Citi's 2024 Global Healthcare Conference
  PRINCETON, N.J.--(BUSINESS WIRE)--November 26, 2024--
  Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in Citi's 2024 Global Healthcare Conference.
Nov 25, 2024
- Bernstein Adjusts Price Target on Bristol-Myers Squibb to $62 From $56, Keeps Market Perform Rating, from 6:06AM ET on Monday Nov 25, 2024 by MT Newswires
  6:06AM ET on Monday Nov 25, 2024 by MT Newswires
  Companies Mentioned: BMY
  06:06 AM EST, 11/25/2024 (MT Newswires) -- Bristol-Myers Squibb (BMY) has an average rating of hold and mean price target of $58.90, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from major ban...
Nov 22, 2024
- DJ Pension Doubles Its Palantir Stake and Buys Up Intel and CVS. -- Barron's, from 9:30PM ET on Friday Nov 22, 2024 by Dow Jones
  9:30PM ET on Friday Nov 22, 2024 by Dow Jones
  Companies Mentioned: INTC, PLTR, BMY, CVS
  
  Ed Lin
  
  One of the largest U.S. pensions recently made a big bet on two tech stocks and a healthcare company, slashing a position in a drug maker.
  
  The State of Michigan Retirement Systems doubled a stake in Palantir Technologies, bought up Intel stock, and increased a stake in CVS Health, while it significantly reduced an investment in Bristol Myers Squibb. The pension reported the stock trades, among others, in a form it filed with the Securities and Exchange Commission.
Nov 19, 2024
- Bristol Myers Squibb's Presentations at ASH 2024 Reinforce Strength of Hematology Portfolio and Scientific Advances in Differentiated Research Platforms, from 6:59AM ET on Tuesday Nov 19, 2024 by Dow Jones
  6:59AM ET on Tuesday Nov 19, 2024 by Dow Jones
  Companies Mentioned: BMY
  
  Bristol Myers Squibb is inspired by a single vision--transforming patients' lives through science. The goal of the company's cancer research is to deliver medicines that offer each patient a better, healthier life and to make cure a possibility. Building on a legacy across a broad range of cancers that have changed survival expectations for many, Bristol Myers Squibb researchers are exploring new frontiers in personalized medicine, and through innovative digital platforms, are turning data into insights that sharpen their focus. Deep understanding of causal human biology, cutting-edge capabilities and differentiated research platforms uniquely position the company to approach cancer from every angle.

Nov 29, 2024
- DJ AstraZeneca PLC Stock Falls Friday, Underperforms Market, from 12:01PM ET on Friday Nov 29, 2024 by Dow Jones
  12:01PM ET on Friday Nov 29, 2024 by Dow Jones
  Companies Mentioned: AZN
- Astrazeneca's Enhertu, Orpathys Among 91 Drugs Added to China's National Reimbursement Drug List, from 8:09AM ET on Friday Nov 29, 2024 by MT Newswires
  8:09AM ET on Friday Nov 29, 2024 by MT Newswires
  Companies Mentioned: JNJ, MRK, SNY, ZLAB, AZN, BMY, BGNE
- AZN ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by AstraZeneca PLC, from 8:01AM ET on Friday Nov 29, 2024 by Accesswire
  8:01AM ET on Friday Nov 29, 2024 by Accesswire
  Companies Mentioned: AZN
- AZN ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by AstraZeneca PLC, from 8:01AM ET on Friday Nov 29, 2024 by Dow Jones
  8:01AM ET on Friday Nov 29, 2024 by Dow Jones
  Companies Mentioned: AZN
- Berenberg Adjusts Price Target on Pfizer to $29 From $27, Maintains Hold Rating, from 5:23AM ET on Friday Nov 29, 2024 by MT Newswires
  5:23AM ET on Friday Nov 29, 2024 by MT Newswires
  Companies Mentioned: PFE
Nov 28, 2024
- DJ AstraZeneca PLC Stock Rises Thursday, Outperforms Market, from 12:01PM ET on Thursday Nov 28, 2024 by Dow Jones
  12:01PM ET on Thursday Nov 28, 2024 by Dow Jones
  Companies Mentioned: AZN
Nov 27, 2024
- AZN ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your AstraZeneca PLC investment, from 12:16PM ET on Wednesday Nov 27, 2024 by Accesswire
  12:16PM ET on Wednesday Nov 27, 2024 by Accesswire
  Companies Mentioned: AZN
- AZN ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your AstraZeneca PLC investment, from 12:16PM ET on Wednesday Nov 27, 2024 by Dow Jones
  12:16PM ET on Wednesday Nov 27, 2024 by Dow Jones
  Companies Mentioned: AZN
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC - AZN, from 12:02PM ET on Wednesday Nov 27, 2024 by Accesswire
  12:02PM ET on Wednesday Nov 27, 2024 by Accesswire
  Companies Mentioned: AZN
- DJ AstraZeneca PLC Stock Rises Wednesday, Outperforms Market, from 12:01PM ET on Wednesday Nov 27, 2024 by Dow Jones
  12:01PM ET on Wednesday Nov 27, 2024 by Dow Jones
  Companies Mentioned: AZN

Bristol-Myers Squibb Co
NYSE:BMYUnited States

Search Criteria

Nov 29, 2024

Astrazeneca's Enhertu, Orpathys Among 91 Drugs Added to China's National Reimbursement Drug List, from 8:09AM ET on Friday Nov 29, 2024 by MT Newswires

Nov 26, 2024

Bristol Myers Squibb to Participate in Citi's 2024 Global Healthcare Conference, from 6:59AM ET on Tuesday Nov 26, 2024 by Dow Jones

Nov 25, 2024

Bernstein Adjusts Price Target on Bristol-Myers Squibb to $62 From $56, Keeps Market Perform Rating, from 6:06AM ET on Monday Nov 25, 2024 by MT Newswires

Nov 22, 2024

DJ Pension Doubles Its Palantir Stake and Buys Up Intel and CVS. -- Barron's, from 9:30PM ET on Friday Nov 22, 2024 by Dow Jones

Nov 19, 2024

Bristol Myers Squibb's Presentations at ASH 2024 Reinforce Strength of Hematology Portfolio and Scientific Advances in Differentiated Research Platforms, from 6:59AM ET on Tuesday Nov 19, 2024 by Dow Jones

Peers Headlines

Nov 29, 2024

DJ AstraZeneca PLC Stock Falls Friday, Underperforms Market, from 12:01PM ET on Friday Nov 29, 2024 by Dow Jones

Astrazeneca's Enhertu, Orpathys Among 91 Drugs Added to China's National Reimbursement Drug List, from 8:09AM ET on Friday Nov 29, 2024 by MT Newswires

AZN ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by AstraZeneca PLC, from 8:01AM ET on Friday Nov 29, 2024 by Accesswire

AZN ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by AstraZeneca PLC, from 8:01AM ET on Friday Nov 29, 2024 by Dow Jones

Berenberg Adjusts Price Target on Pfizer to $29 From $27, Maintains Hold Rating, from 5:23AM ET on Friday Nov 29, 2024 by MT Newswires

Nov 28, 2024

DJ AstraZeneca PLC Stock Rises Thursday, Outperforms Market, from 12:01PM ET on Thursday Nov 28, 2024 by Dow Jones

Nov 27, 2024

AZN ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your AstraZeneca PLC investment, from 12:16PM ET on Wednesday Nov 27, 2024 by Accesswire

AZN ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your AstraZeneca PLC investment, from 12:16PM ET on Wednesday Nov 27, 2024 by Dow Jones

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC - AZN, from 12:02PM ET on Wednesday Nov 27, 2024 by Accesswire

DJ AstraZeneca PLC Stock Rises Wednesday, Outperforms Market, from 12:01PM ET on Wednesday Nov 27, 2024 by Dow Jones